Keywords: fda, confirms, barr, laboratories, generic, tamoxifen, right

FDA confirms Barr Laboratories' generic tamoxifen right

Article | 11 March 1999

Print This

- The US Food and Drug Administration has affirmed BarrLaboratories' right to 180 days of market exclusivity for its generic version of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in